SCHEMBL8891079

SCHEMBL8891079

COc1cccc(Nc2nc(Nc3ccc(O)cc3)nc3ccccc23)c1

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPY5R Q15761 4/20 0.72
HTT P42858 3/20 0.67
KDM4E B2RXH2 2/20 0.67
TAAR1 Q96RJ0 1/20 0.67
MEN1 O00255 3/20 0.63
KMT2A Q03164 3/20 0.63
AURKA O14965 1/20 0.63
RXFP1 Q9HBX9 1/20 0.63
ABCG2 Q9UNQ0 8/20 0.63
ABCB1 P08183 5/20 0.61
PDE5A O76074 1/20 0.61
MERTK Q12866 2/20 0.60
DYRK3 O43781 1/20 0.57
MAP4K4 O95819 1/20 0.57
EGFR P00533 1/20 0.57
PDGFRA P16234 1/20 0.57
LTK P29376 1/20 0.57
GRK5 P34947 1/20 0.57
KDR P35968 1/20 0.57
MAPK8 P45983 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL8898320 0.99 NPY5R (0.70) NPY5RHTTKDM4ETAAR1MEN1
SCHEMBL8891851 0.93 NPY5R (0.78) NPY5RHTTKDM4ETAAR1MEN1
Hydrochloric Acid SCHEMBL8899399 0.92 NPY5R (0.76) NPY5RHTTKDM4ETAAR1MEN1
SCHEMBL8889167 0.92 NPY5R (0.76) NPY5RHTTKDM4ETAAR1MEN1
Hydrochloric Acid SCHEMBL8907334 0.91 NPY5R (0.83) NPY5RHTTKDM4ETAAR1MEN1
Hydrochloric Acid SCHEMBL8907425 0.91 HTT (0.75) NPY5RHTTKDM4ETAAR1MEN1
SCHEMBL8892916 0.89 NPY5R (0.85) NPY5RTAAR1MEN1KMT2AABCG2
Hydrochloric Acid SCHEMBL8898666 0.88 NPY5R (0.83) NPY5RHTTTAAR1MEN1KMT2A
SCHEMBL27465314 0.87 ABCG2 (0.72) NPY5RHTTKDM4ETAAR1MEN1
SCHEMBL8899542 0.87 NPY5R (0.69) NPY5RMEN1KMT2AAURKAMERTK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1997020822-A1 QUINAZOLIN-2,4-DIAZIRINES AS NPY RECEPTOR ANTAGONIST NOVARTIS AG (CH) 1997-06-12 WO claimed